By David Tuller, DrPH Last summer, the US Centers for Disease Control removed graded exercise therapy and cognitive behavior therapy from its website as recommendations for treatment of the illness…
By David Tuller, DrPH A British medical education company has recently disseminated a recruitment ad for a high-profile pediatric study of treatment for what it calls CFS/ME. The recruitment ad’s…
By David Tuller, DrPH Yet another interesting development has taken place at Cochrane, and this new development again suggests that things there might be moving in the right direction. On…
By David Tuller, DrPH I spent the last week of November in Oslo. The Norwegian ME Association invited me to give a couple of talks and have some meetings with…
By David Tuller, DrPH I was surprised recently when the UK press made a big splash about what was, in the end, a modest study from a team led by…
By David Tuller, DrPH As Virology Blog has reported, the lead author of the revised version of Cochrane’s Risk of Bias tool, published last week in BMJ, is a long-time…
